Silver Book Fact

Use of tamoxifen, a drug used to treat breast cancer, has resulted in a direct cost savings of $41,372 per year of life gained in women 35- to 49-years-old, $68,349 in women 50- to 59-years-old, and $74,981 in women 60 to 69.

Joint Economic Committee. The Benefits of Medical Research and the Role of NIH. Apr-2000;

Reference

Title
The Benefits of Medical Research and the Role of NIH
Publisher
United States Senate: Office of the Chairman, Connie Mack
Publication Date
Apr-2000
Authors
Joint Economic Committee

Categories

  • Innovative Medical Research
  • Economic Value

Related Facts

  • From 2007 to 2011, lung cancer incidence rates decreased by three percent each year in men and 2.2 percent each year in women.  
  • Over the next 10 years, the number of cancer survivors in the U.S. is predicted to grow from 14.5 million to nearly 19 million (9.3 million men and 9.6 million…  
  • According to the Pharmaceutical Research and Manufacturers of America, researchers are currently working on 646 medicines for cancer. All are either in clinical trials or under FDA review. …  
  • A drug for testicular cancer that cost an estimated $56 million to develop led to a sharp increase in survival rate and an annual return of $166 million in treatment…  
  • Following the current path, the prostate cancer incidence rate will increase by 75.4% (786,000) between 2003 and 2023. If an alternative path is taken, there will be 21.5% (393,000) fewer…